Navigation Links
AMN Healthcare Announces First Quarter 2009 Results
Date:5/7/2009

ance with accounting rule FAS 142, the company incurred $176 million in non-cash impairment charges relating to goodwill and certain other intangible assets resulting from a combination of the company's depressed equity market value and lower projected near-term growth rates for the healthcare staffing industry. These trends reflect the current downturn in the U.S. economy in general and, in particular, the continued deterioration in labor markets since the beginning of 2009. These impairment charges are non-cash expenses and will not have any impact on the company's cash position, future cash flows or debt covenants.

First quarter GAAP net loss per diluted share was ($3.74) and included the negative impacts of $3.78 of non-cash goodwill and other intangible asset impairment charges, $0.05 of restructuring charges and $0.02 of non-recurring legal costs.

Total debt outstanding at March 31, 2009 was $119.5 million, yielding a leverage ratio of 1.3. Total average diluted shares outstanding for the first quarter of 2009 were 32.6 million.

Credit Facility Update

The company has secured an amendment to its credit agreement that increases the maximum allowable leverage ratio and extends the revolver tenor one year to match that of the term loan. The interest rate on the term debt remains unchanged at LIBOR plus 1.75% and the rate on the revolver increases 2.0%.

Business Trends and Outlook

During the first quarter of 2009 and first month of the second quarter, the general business trends have been as follows: demand for travel nurse professionals declined significantly during the first part of the year but has recently begun to show signs of stabilization, and demand for allied professionals has been growing, but both are still at levels considerably lower than prior year. Locum tenens volume (days filled) has been relatively flat but is expected to increase
'/>"/>

SOURCE AMN Healthcare Services, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. Quest Diagnostics to Speak at the Bank of America and Merrill Lynch 2009 Healthcare Conference
2. HMS Holdings Corp. to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference
3. MedPage Today(R) Named Best Online Healthcare Publication
4. ViroPharma to Present at Two May Healthcare Conferences
5. Decho Doubles Number of Mozy Healthcare Customers
6. NuVasive to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference
7. Physicians Choice Leverages InstaMeds Integrated Platform for Healthcare Payment & Clearinghouse Solutions
8. Symmetry Medical to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference
9. AMN Healthcare Services to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference and at the Robert W. Baird 2009 Growth Stock Conference
10. South Africa not Gaining the Full Benefit of PPPs in the Healthcare Sector, Says Frost & Sullivan
11. Ohio Selects APS Healthcare to Manage Unified Population Health Management Program for State Employees
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... The market for botulinum neurotoxin (BoNT) ... owing to novel medical indications created and due to ... societies where physical appearance is extremely valued. Although the ... competitors, new companies and technologies are setting ground for ... put the price of 1st-gen products under pressure, only ...
(Date:7/22/2014)... HealthDay Reporter TUESDAY, July 22, ... invasive procedure known as morcellation carries a risk of spreading ... more clearly. Twenty-seven of every 10,000 women who had ... the procedure, researchers found, with the odds being highest for ... hysterectomy with morcellation use a power cutter to slice uterine ...
(Date:7/22/2014)... French . Montreal, ... step out for a cigarette twice as often as smokers ... who have the hardest time shaking off the habit may ... of. , Those insights were among the collective findings recently ... by a team of researchers based in part at Concordia ...
(Date:7/22/2014)... 22, 2014 5i Sciences, a medical ... appointment of Molly Coye, M.D., M.P.H. to a role ... renowned authority on the market introduction of innovative technologies ... she will advise on strategies for building a successful ... technology. Dr. Coye is currently the Chief Innovation ...
(Date:7/22/2014)... 2014 The Latin America Drilling fluid and ... and completion fluid market in Latin America with analysis and ... in Latin America is estimated to grow from around $0.93 ... CAGR of 9.2%, for the given period. , Browse through ... fluid Market Report, to get an idea of the in-depth ...
Breaking Medicine News(10 mins):Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 2Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 3Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 4Health News:Technique Used in Some Hysterectomies May Help Spread Cancer: Study 2Health News:Technique Used in Some Hysterectomies May Help Spread Cancer: Study 3Health News:Extra exercise helps depressed smokers kick the habit faster 2Health News:5i Sciences Announces Appointment of a Senior Healthcare Consultant and Successful Financing 2Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 2Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 3Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 4Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 5Health News:Latin America Drilling Fluid & Completion Fluid Market is Expected to Reach $1.45 Billion in 2018 - New Report by MicroMarket Monitor 6
... Announces 2008,Journalistic Achievement Awards, NEW YORK, May ... Show are among winners receiving top honors,in the ... for Aesthetic Plastic Surgery (ASAPS). Selected from among ... their awards on May,6th, at ASAPS, Annual Meeting ...
... $12.5 million private placement, SHANGHAI, China, May ... or "ATG") (OTC Bulletin Board: AAXT),today announced that, ... of all the outstanding common stock of Asian ... ("ABM"),pursuant to a share exchange agreement. ATG acquired ...
... Many women under age 55 arent seeking timely treatment for ... reaction to follow a Hollywood script tightening in the ... one knee. , Thats the finding of researchers who presented ... on Quality of Care and Outcomes Research (QCOR) in Cardiovascular ...
... Finding could help men with precancerous lesions avoid unnecessary ... Spanish researchers report they may have found a way ... develop into cancer. , The findings, published in the ... show a link between high-grade prostatic intraepithelial neoplasia (HG-PIN) ...
... Wound Closure System earns high marks from ... combat surgeons, ... U.S. Army combat support surgeons in Baghdad show that a new,medical device ... and limbs of soldiers and civilians., A team of battle zone ...
... the Decade Announced at Special 10th Anniversary ... Ceremony in Washington, DC -, ... honor six inspiring winners at the 10th annual Welcome Back Awards,ceremony ... the,Welcome Back Awards has recognized individuals for their outstanding,commitments to mental ...
Cached Medicine News:Health News:Aesthetic Society Awards Journalists' Commitment to Patient Education 2Health News:Aesthetic Society Awards Journalists' Commitment to Patient Education 3Health News:Shanghai Medical Technology Co., Ltd. Completes Merger With Aamaxan Transport Group, Inc. 2Health News:Shanghai Medical Technology Co., Ltd. Completes Merger With Aamaxan Transport Group, Inc. 3Health News:Shanghai Medical Technology Co., Ltd. Completes Merger With Aamaxan Transport Group, Inc. 4Health News:Some women more likely to miss or ignore heart attack warning signs 2Health News:Some women more likely to miss or ignore heart attack warning signs 3Health News:Biomarker Spots Which Lesions Likely to Progress to Prostate Cancer 2Health News:New Surgical Device Saves Lives and Limbs on Iraq's Front Lines 2Health News:New Surgical Device Saves Lives and Limbs on Iraq's Front Lines 3Health News:2008 Welcome Back Awards Winners Honored for Extraordinary Achievements in the Field of Depression 2Health News:2008 Welcome Back Awards Winners Honored for Extraordinary Achievements in the Field of Depression 3Health News:2008 Welcome Back Awards Winners Honored for Extraordinary Achievements in the Field of Depression 4Health News:2008 Welcome Back Awards Winners Honored for Extraordinary Achievements in the Field of Depression 5Health News:2008 Welcome Back Awards Winners Honored for Extraordinary Achievements in the Field of Depression 6
(Date:7/22/2014)... , July 22, 2014  Neurotrope Bioscience, Inc., ... a world-wide, exclusive license agreement with the Icahn School ... ( Mount Sinai ) to utilize its ... Bryostatin-1 in the treatment of Niemann-Pick Type C Disease ... afflicted with Alzheimer-like symptoms. The license also covers other ...
(Date:7/22/2014)...  According to the American Optometric Association (AOA), parents ... devices. An AOA survey reports that 83 percent of ... they use an electronic device for three or more ... parents revealed that only 40 percent of parents believe ... amount of time. Eye doctors are concerned that this ...
(Date:7/22/2014)... MARCOS, Texas , July 22, 2014 Quantum Materials ... and Mr. John Heaton to the Board of ... by Dr. Ghassan Jabbour , QMC Chief Science Officer and ... Michael Wong of Rice University and Mr. Tomio ... Japan . " Quantum Materials welcomes ...
Breaking Medicine Technology:Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 2Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 4Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 5Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 2Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 3Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 4Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 2Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 3Quantum Materials Announces New Outside Directors and Adds Scientific Advisory Board 4
... Pharmaceuticals, Inc. announced today that the U.S. Food ... drug status for the treatment of pancreatic cancer. ... the marketed chemotherapy drug irinotecan.  MM-398 is partnered ... Taiwan under the designation PEP02. (Logo: ...
... Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) today announced ... the NASDAQ Global Select Market closes on Tuesday, August 9, ... Executive Officer, will host a conference call and webcast at ... the financial results for the second quarter 2011 and to ...
Cached Medicine Technology:FDA Grants Orphan Drug Status to Merrimack Pharmaceuticals' MM-398, a Nanotherapeutic Encapsulation of Irinotecan, for the Treatment of Pancreatic Cancer 2Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 9 2Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 9 3
... stools come with five legs for extra ... 25" (total vertical travel 6"). 2" ball ... and fire retardant upholstery, available in black ... special order. Features a contoured, padded, upholstered ...
Lacrimal Cannulas, 19 g. shaft tapering to 23 g. cannula, straight. Overall length 37.5 mm. 5/box....
Anterior Chamber Needle, 21 g., 8 mm from bend to tip. Overall length 25 mm. 5/box....
Nucleus Hydrodissection Cannula, 25 g. Angled with flattened tip. 7 mm angled shaft with flattened tip for insertion under the capsular flap. Overall length 19 mm. 5/box....
Medicine Products: